Clinical trial
A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
NCT00317356 · Otsuka Pharmaceutical Co., Ltd., Industry · Terminated
Key facts
| NCT number | NCT00317356 |
|---|---|
| Title | A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis |
| Official title | A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colitis, Ulcerative |
| Intervention type | Drug |
| Interventions | OPC-6535(Tetomilast) |
| Enrollment | 43 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 24, 2006 |
| Last update posted | Apr 30, 2021 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: